Craft

Advanced
  • Home
  •  / AnHeart Therapeutics
AnHeart Therapeutics

AnHeart Therapeutics

AnHeart Therapeutics Summary

Company Summary

Overview
AnHeart Therapeutics (AHT, 葆元生物医药科技) is a company dedicated to the development of late clinical-stage oncology drugs. Its AB-106 product is a selective ROS1 and NTRK1-3 dual-target inhibitor.
Type
Private
Status
Active
Founded
2018
HQ
New York, NY, US | view all locations
Website
http://anhearttherapeutics.com
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Fan Frank Fan

    Fan Frank Fan, Senior Vice President & Head of Clinical Development Strategy

    • Jun Li, Vice President of Pre-Clinical

      • Yizhong Ren, Director of Medical Science Liaison

        • Juan Pan, Director of Data Management

          LocationsView all

          1 location detected

          • New York, NY HQ

            United States

            777 Third Avenue, Suite 1704

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2024
          Share price data provided by IEX